David S Egilman

11PUBLICATIONS
7CO-AUTHORS
Medical infection agents (incl. prions)Commercial lawData security and protectionTaxation lawBioprocessing, bioproduction and bioproducts
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 16, 2021
A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases.

Triet Tran, David Egilman, Mark Rigler

|Mar 01, 2021
A Review of the Talc Industry's Influence on Federal Regulation and Scientific Standards for Asbestos in Talc.

Tess Bird, Joan E Steffen, Triet H Tran

|Aug 22, 2018
Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example.

David Egilman, Tess Bird, Remi Wilson

|Aug 21, 2018
Commentary on "Assessment of Health Risk From Historical Use of Cosmetic Talcum Powder".

David Egilman, Joan Steffen

|May 02, 2018
The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study.

David Egilman

|May 25, 2016
A commentary on Roggli's "The So-Called Short-Fiber Controversy".

David Egilman, Triet Tran

Pageof 2

Frequent Collaborators

2 joint publications

Tess Bird

2 joint publications

Triet Tran

1 joint publications

David Madigan

1 joint publications

Triet Tran